LakeShore Biopharma Company Insiders

LakeShore Biopharma Management Team Effectiveness

The company has Return on Asset of (0.1385) % which means that on every $100 spent on assets, it lost $0.1385. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6599) %, meaning that it generated no profit with money invested by stockholders. LakeShore Biopharma's management efficiency ratios could be used to measure how well LakeShore Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.29. In addition to that, Return On Capital Employed is expected to decline to -0.66. At present, LakeShore Biopharma's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 10.1 M, whereas Total Assets are forecasted to decline to about 944.3 M. As of December 3, 2024, Common Stock Shares Outstanding is expected to decline to about 66.7 M

LakeShore Biopharma Workforce Comparison

LakeShore Biopharma Profit Margins

The company has Net Profit Margin of (0.76) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.69) %, which entails that for every $100 of revenue, it lost $0.69.

LakeShore Biopharma Co, Benchmark Summation

LakeShore Biopharma Notable Stakeholders

The success or failure of an entity such as LakeShore Biopharma Co, often depends on how effective the management is. LakeShore Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LakeShore management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LakeShore management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of LakeShore Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LakeShore Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of LakeShore Biopharma's management manipulating its earnings.

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.